The 11th International Conference on Transfer Factor, organized by the University of Nuevo Leon and professors Rayes Tamez Guerra and Cristina Rodrigez Padilla, was held in Monterrey, Mexico, March 1-4. The field has dwindled from its glorious days in the 1970s, due to the rejection of the concept of transfer of antigen-specific information to uncommitted lymphocytes using a structurally unidentified low-molecular-weight cell extract. But clinical research continues in several parts of the world, mainly in developing countries.

Once again, the reported clinical results were important, and theoretically, should warrant funding to further explore the phenomenon and exploit its uses for patients' benefit. Indeed, from viral and fungal infections to malignant disorders, from herpes to tuberculosis, transfer factor has proven able to stimulate immune defenses, preventing new infections or relapses and shortening the course of disease.

Giancarlo Pizza (Bologna, Italy), The International Transfer Factor Society's new president and the only Westerner...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?